Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #40381
advertisement
Sun C
61
Showing records 1 to 25 |
Display all abstracts from
Sun C
117032
A molecular switch for neuroprotective astrocyte reactivity
Cameron EG
Nature
2024; 626: 574-582
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Xue X
Computers in Biology and Medicine
2024; 174: 108399
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
He C
Journal of Neuroinflammation
2024; 21: 43
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Kim S
Ophthalmology science
2024; 4: 100533
117649
The Beijing angle closure progression study: design and methodology
Liang ZQ
Frontiers in medicine
2024; 11: 1385060
117032
A molecular switch for neuroprotective astrocyte reactivity
Nahmou M
Nature
2024; 626: 574-582
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Peng K
Journal of Neuroinflammation
2024; 21: 43
117649
The Beijing angle closure progression study: design and methodology
Yang KY
Frontiers in medicine
2024; 11: 1385060
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Zhang D
Computers in Biology and Medicine
2024; 174: 108399
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Chen V; Pottenburgh J
Ophthalmology science
2024; 4: 100533
117032
A molecular switch for neuroprotective astrocyte reactivity
Toth AB
Nature
2024; 626: 574-582
117649
The Beijing angle closure progression study: design and methodology
Lv K
Frontiers in medicine
2024; 11: 1385060
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Zhu X
Journal of Neuroinflammation
2024; 21: 43
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Sun C
Computers in Biology and Medicine
2024; 174: 108399
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Pottenburgh J
Ophthalmology science
2024; 4: 100533
117649
The Beijing angle closure progression study: design and methodology
Ma Y
Frontiers in medicine
2024; 11: 1385060
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cruz M
Ophthalmology science
2024; 4: 100533
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Shi Y
Computers in Biology and Medicine
2024; 174: 108399
117032
A molecular switch for neuroprotective astrocyte reactivity
Heo L
Nature
2024; 626: 574-582
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Wang Z; Xiu W
Journal of Neuroinflammation
2024; 21: 43
117649
The Beijing angle closure progression study: design and methodology
Sun C
Frontiers in medicine
2024; 11: 1385060
117032
A molecular switch for neuroprotective astrocyte reactivity
Tanasa B
Nature
2024; 626: 574-582
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cooper G
Ophthalmology science
2024; 4: 100533
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Wang R
Computers in Biology and Medicine
2024; 174: 108399
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Sun C
Ophthalmology science
2024; 4: 100533
«
1
2
3
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept